Truist Financial Sticks to Its Hold Rating for Organogenesis Holdings (ORGO)Tip Ranks·Aug 13 at 02:26 AMORGO-2.52%
The Tangible and the Abstract: What UWM’s Derivative Blowup Teaches Us About Business ModelsGlobal Report·Aug 11 at 10:13 AMORGO-2.52%VAC+3.26%
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga_article·Aug 7 at 05:05 PMCVRX+0.66%EMBC+0.78%
Truist Financial Has Lowered Expectations for Organogenesis (NASDAQ:ORGO) Stock PriceMarket Beat·Aug 7 at 01:36 PMORGO-2.52%
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga_article·Aug 7 at 12:05 PMNTRA+4.82%QDEL+3.34%
Trade Desk Posts Downbeat Q2 Results, Joins Sezzle, Resmed, Ouster And Other Big Stocks Moving Lower In Friday’s Pre-Market Sessionbenzinga_article·Aug 7 at 12:02 PMOUSTZ0.00%ARDX-0.15%
Organogenesis enters $75 million at-the-market equity sales agreementPUBT·Aug 6 at 10:15 PMORGO-2.52%
Organogenesis Q2 2026 earnings: Wound care decline compresses marginsTradingKey·Aug 6 at 09:48 PMORGO-2.52%
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga_article·Aug 6 at 09:06 PMHCAT+4.34%QDEL+3.34%
Organogenesis Q2 2026 net loss widens to $96.3 million; net revenue drops 58% to $42.8 million vs Q2 2025PUBT·Aug 6 at 08:44 PMORGO-2.52%
Organogenesis (ORGO) to Release Quarterly Earnings on ThursdayMarket Beat·Jul 30 at 09:11 AMORGO-2.52%
Organogenesis says RCT shows Affinity lifts venous leg ulcer closure rates at weeks 12 and 16PUBT·Jul 27 at 08:06 PMORGO-2.52%
